Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR vs ROFLUMILAST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-PVVR vs ROFLUMILAST: Safety Overview

Metric RITUXIMAB-PVVR ROFLUMILAST
Total FAERS Reports 4,210 2,700
Deaths Reported 415 645
Death Rate 9.9% 23.9%
Hospitalizations 966 625
Average Patient Age 60.4 yrs 68.8 yrs
% Female Patients 67.9% 56.3%
FDA Approval Date N/A Apr 17, 2023
Manufacturer N/A Aurobindo Pharma Limited
Route N/A ORAL
Marketing Status Prescription Prescription